TCF7L2 and diabetes mellitus: TCF7L2 can notably be activated by β2 adrenoreceptor agonists33 and can also influence the transcription of a number of other GPCRs, thereby implicated in a large variety of diseases, especially diabetes, through however, uncharacterized mechanisms31, 32, 35.